A Novel Formulation of Epoprostenol with Antimicrobial Properties, Administered Under Ambient Conditions, for Treatment of Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Witchey-Lakshmanan, L.
Palepu, N.
Teja, B. B.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2010年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3364
引用
收藏
页数：1
相关论文
共 50 条
  • [21] How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 23 - 32
  • [22] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Demerouti, Eftychia
    Karyofyllis, Panagiotis
    Manginas, Athanassios
    Anthi, Anastasia
    Karatasakis, George
    Athanassopoulos, George
    Voudris, Vassilios
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (02) : 99 - 105
  • [23] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Eftychia Demerouti
    Panagiotis Karyofyllis
    Athanassios Manginas
    Anastasia Anthi
    George Karatasakis
    George Athanassopoulos
    Vassilios Voudris
    American Journal of Cardiovascular Drugs, 2019, 19 : 99 - 105
  • [24] EPITOME-2: Evaluation of a new formulation of epoprostenol sodium in pulmonary arterial hypertension patients switched from an originally approved formulation
    Sitbon, Olivier
    Delcroix, Marion
    Bergot, Emmanuel
    Boonstra, Anco
    Escribano Subias, Pilar
    Galie, Nazzareno
    Granton, John
    Langleben, David
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] Urticaria induced by continuous intravenous epoprostenol treatment in a patient with pulmonary arterial hypertension
    Sawada, Tomoya
    Kuwai, Takumi
    Nakajima, Saeko
    Chen-Yoshikawa, Toyofumi Fengshi
    Nomura, Takashi
    Date, Hiroshi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2024,
  • [26] Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
    Robbins, IM
    Gaine, SP
    Schilz, R
    Tapson, VF
    Rubin, LJ
    Loyd, JE
    CHEST, 2000, 117 (01) : 14 - 18
  • [27] Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
    Horn, EM
    Barst, RJ
    Poon, M
    CHEST, 2000, 118 (04) : 1229 - 1230
  • [28] Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Greig, Sarah L.
    Scott, Lesley J.
    Plosker, Greg L.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 463 - 470
  • [29] Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension
    Miura, Yohei
    Kataoka, Masaharu
    Chiba, Tomohiro
    Inami, Takumi
    Yoshino, Hideaki
    Satoh, Toru
    CIRCULATION JOURNAL, 2018, 82 (10) : 2676 - 2677
  • [30] Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
    Chebib, Nader
    Cottin, Vincent
    Taharo-Ag-Ralissoum, Martine
    Chuzeville, Michel
    Mornex, Jean-Francois
    PULMONARY CIRCULATION, 2018, 8 (01)
12345